ResMed Stock Forecast

Stock Price Forecast

The 11 analysts with 12-month price forecasts for ResMed stock have an average target of 292.27, with a low estimate of 269 and a high estimate of 330. The average target predicts an increase of 13.92% from the current stock price of 256.55.

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$269	$292.27	$299	$330
Change	+4.85%	+13.92%	+16.55%	+28.63%

* Price targets were last updated on Nov 3, 2025.

Analyst Ratings

The average analyst rating for ResMed stock from 13 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Jul '25	Aug '25	Sep '25	Oct '25	Nov '25	Dec '25
Strong Buy	3	3	3	2	2	2
Buy	6	6	6	6	7	7
Hold	3	3	3	4	4	4
Sell	1	1	1	0	0	0
Strong Sell	0	0	0	0	0	0
Total	13	13	13	12	13	13

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Joe Vruwink Baird	Baird	Buy Maintains $320 → $300	Buy	Maintains	$320 → $300	+16.94%	Nov 3, 2025
Craig Wong-Pan RBC Capital	RBC Capital	Buy Maintains $300 → $303	Buy	Maintains	$300 → $303	+18.11%	Oct 31, 2025
Brett Fishbin Keybanc	Keybanc	Buy Maintains $298 → $299	Buy	Maintains	$298 → $299	+16.55%	Oct 31, 2025
Anthony Petrone Mizuho	Mizuho	Buy Maintains $310 → $300	Buy	Maintains	$310 → $300	+16.94%	Oct 31, 2025
Sean Laaman Morgan Stanley	Morgan Stanley	Buy Maintains $298 → $304	Buy	Maintains	$298 → $304	+18.50%	Oct 21, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

5.65B

from 5.15B

9.81%

from 5.15B

Revenue Next Year

6.06B

from 5.65B

7.31%

from 5.65B

EPS This Year

10.97

from 9.51

15.38%

from 9.51

EPS Next Year

12.10

from 10.97

10.28%

from 10.97

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Jun 30, 2021	Jun 30, 2022	Jun 30, 2023	Jun 30, 2024	Jun 30, 2025	Jun 30, 2026	Jun 30, 2027
Revenue	3.20B	3.58B	4.22B	4.69B	5.15B	5.65B	6.06B
Revenue Growth	8.11%	11.93%	18.02%	10.95%	9.84%	9.81%	7.31%
EPS	3.24	5.30	6.09	6.92	9.51	10.97	12.10
EPS Growth	-24.12%	63.58%	14.91%	13.63%	37.43%	15.38%	10.28%
Forward PE	-	-	-	-	-	23.38	21.20
No. Analysts	-	-	-	-	-	22	22

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027
High	6.0B	6.5B
Avg	5.7B	6.1B
Low	5.4B	5.8B

Revenue Growth

Revenue Growth	2026	2027
High	15.6%	14.5%
Avg	9.8%	7.3%
Low	5.3%	2.5%

EPS Forecast

EPS	2026	2027
High	11.71	13.21
Avg	10.97	12.10
Low	10.14	11.40

EPS Growth

EPS Growth	2026	2027
High	23.1%	20.4%
Avg	15.4%	10.3%
Low	6.7%	3.9%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.